Delinia, Inc.
Records under this name other than the patents Delinia, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 6 of 6 · Back to Delinia, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,035,836 | Modified IL-2 Variants That Selectively Activate Regulatory T Cells Lapsed on the fee record Ended Jul 31, 2026 · High confidence | Lapsed on the fee record | Ended Jul 31, 2026 | High confidence |
| US 11,077,172 | IL-2 variants for the treatment of psoriasis Lapsed on the fee record Ended Aug 3, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 3, 2025 | From the USPTO record |
| US 11,059,877 | Multivalent regulatory T cell modulators Lapsed on the fee record Ended Jul 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 13, 2025 | From the USPTO record |
| US 10,875,901 | Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases Lapsed on the fee record Ended Dec 29, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 29, 2024 | From the USPTO record |
| US 10,774,126 | Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases Lapsed on the fee record Ended Sep 15, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 15, 2024 | From the USPTO record |
| US 10,766,938 | Nucleic acid encoding human IL-2 variant Lapsed on the fee record Ended Sep 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2024 | From the USPTO record |